Literature DB >> 22563105

Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults.

Konstantinos N Aronis1, Joo-Pin Foo, John P Chamberland, Christos S Mantzoros.   

Abstract

INTRODUCTION: Osteoprotegerin (OPGN) is a bone-remodeling marker that is associated with various metabolic and vascular complications. Cross-sectional studies in humans have demonstrated an inverse association between leptin, a marker of energy sufficiency, and OPGN. The physiology of OPGN has not been fully elucidated to date. We thus aim to elucidate 1) whether OPGN levels exhibit any gender dimorphism or day/night secretion pattern; and 2) whether there is any effect of acute and/or chronic energy deprivation on its circulating levels and whether such effects are mediated through leptin.
MATERIALS AND METHODS: Study A: To evaluate OPGN secretion patterns and OPGN response to acute energy deprivation, we studied 12 healthy subjects under three different conditions for 72 h-in the isocaloric fed state, and during a fasting state with administration of either placebo or metreleptin in replacement doses. Blood samples were obtained every 15 min and pooled hourly during the last 24 h of the study. Study B: To evaluate the effect of chronic energy deprivation on OPGN secretion, we measured its levels in 14 obese subjects before and during weight loss after bariatric surgery.
RESULTS: OPGN levels exhibited a statistically significant (P < 0.01), albeit clinically limited in magnitude, day/night variation pattern in both genders (R(2) = 14.68%; 10.7-14.8% reduction with lower levels around 1600-1800 h; P < 0.01). Males had lower OPGN levels compared to females (1.81 ± 0.04 vs. 3.65 ± 0.07 pmol/liter; P < 0.001). Three days of fasting with either placebo or metreleptin administration did not change OPGN levels. OPGN levels did not change during bariatric surgery-induced weight loss.
CONCLUSIONS: OPGN levels are lower in men and exhibit a statistically significant, albeit clinically limited in magnitude, day/night secretion pattern. Neither acute nor chronic energy deprivation leading to significant weight loss has any effects on OPGN levels. Nomenclature Comment: Use of the terms "circadian" and "day/night variation" is meant as follows: Circadian pattern is a functional term that implies a rhythm that has been proven to be regulated by the innate circadian apparatus (anatomical and/or molecular). Conversely, day/night variation pattern is a descriptive term that refers to serum levels that vary during a day, usually in a periodic fashion. It is not known whether this variation is an innate property of the organ that secretes this hormone or whether it is determined by exogenous factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563105      PMCID: PMC3410259          DOI: 10.1210/jc.2012-1618

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men.

Authors:  J M Mullington; J L Chan; H P A Van Dongen; M P Szuba; J Samaras; N J Price; H K Meier-Ewert; D F Dinges; C S Mantzoros
Journal:  J Neuroendocrinol       Date:  2003-09       Impact factor: 3.627

2.  Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency.

Authors:  Jean L Chan; Stergios J Moschos; John Bullen; Kathleen Heist; Xian Li; Young-Bum Kim; Barbara B Kahn; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption.

Authors:  A Schlemmer; C Hassager
Journal:  Eur J Endocrinol       Date:  1999-04       Impact factor: 6.664

5.  Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.

Authors:  Elizabeth Sienkiewicz; Faidon Magkos; Konstantinos N Aronis; Mary Brinkoetter; John P Chamberland; Sharon Chou; Kalliopi M Arampatzi; Chuanyun Gao; Anastasia Koniaris; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-07-07       Impact factor: 8.694

6.  Mechanism of circadian variation in bone resorption.

Authors:  N H Bjarnason; E E G Henriksen; P Alexandersen; S Christgau; D B Henriksen; C Christiansen
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

7.  Serum osteoprotegerin in adolescent girls with anorexia nervosa.

Authors:  Madhusmita Misra; Leslie A Soyka; Karen K Miller; David B Herzog; Steven Grinspoon; Dave De Chen; Gregory Neubauer; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

8.  The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men.

Authors:  Jean L Chan; Kathleen Heist; Alex M DePaoli; Johannes D Veldhuis; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

9.  Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.

Authors:  K E Naylor; A Rogers; R B Fraser; V Hall; R Eastell; A Blumsohn
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers.

Authors:  Barbara E Wolfe; David C Jimerson; Christine Orlova; Christos S Mantzoros
Journal:  Clin Endocrinol (Oxf)       Date:  2004-09       Impact factor: 3.478

View more
  1 in total

1.  Gain of Metabolic Benefit with Ablation of miR-149-3p from Subcutaneous Adipose Tissue in Diet-Induced Obese Mice.

Authors:  Shasha Zheng; Shanjun Guo; Gongrui Sun; Yanteng Shi; Zhe Wei; Yuhang Tang; Fangfang He; Chenke Shi; Peng Dai; Hoshun Chong; Isabella Samuelson; Ke Zen; Chen-Yu Zhang; Yujing Zhang; Jing Li; Xiaohong Jiang
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-26       Impact factor: 8.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.